BINEX Co., Ltd. (053030.KQ)
KRW 17490.0
(-3.95%)
KRW 17490.0
(-3.95%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 151.04 KRW | -62.47% |
| 2022 | 402.42 KRW | -34.44% |
| 2021 | 613.78 KRW | 198.56% |
| 2020 | 205.58 KRW | -24.61% |
| 2019 | 272.69 KRW | 33.76% |
| 2018 | 203.86 KRW | 155.51% |
| 2017 | -367.27 KRW | -275.95% |
| 2016 | -97.69 KRW | 57.83% |
| 2015 | -231.64 KRW | 0.0% |
| 2013 | -170.01 KRW | 50.86% |
| 2012 | -346.00 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -315.98 KRW | -660.25% |
| 2024 Q2 | -172.49 KRW | 45.41% |
| 2023 Q1 | 228.43 KRW | 8720.0% |
| 2023 Q2 | 43.99 KRW | -80.74% |
| 2023 FY | - KRW | -62.47% |
| 2023 Q3 | -177.78 KRW | -504.14% |
| 2023 Q4 | 56.40 KRW | 131.72% |
| 2022 Q4 | -2.65 KRW | -101.56% |
| 2022 Q3 | 169.57 KRW | -5.25% |
| 2022 Q2 | 178.97 KRW | 193.78% |
| 2022 FY | - KRW | -34.44% |
| 2022 Q1 | 60.92 KRW | -52.72% |
| 2021 Q1 | 269.62 KRW | 269.38% |
| 2021 Q2 | 55.96 KRW | -79.24% |
| 2021 Q3 | 159.18 KRW | 184.45% |
| 2021 Q4 | 128.84 KRW | -19.06% |
| 2021 FY | - KRW | 198.56% |
| 2020 Q2 | 180.67 KRW | 268.71% |
| 2020 Q3 | 134.55 KRW | -25.53% |
| 2020 Q4 | -159.18 KRW | -218.31% |
| 2020 FY | - KRW | -24.61% |
| 2020 Q1 | 49.00 KRW | -40.96% |
| 2019 Q4 | 83.00 KRW | 53.7% |
| 2019 Q2 | 93.18 KRW | 121.86% |
| 2019 Q1 | 42.00 KRW | -81.75% |
| 2019 FY | - KRW | 33.76% |
| 2019 Q3 | 54.00 KRW | -42.05% |
| 2018 Q2 | -56.96 KRW | -42.9% |
| 2018 FY | - KRW | 155.51% |
| 2018 Q4 | 230.15 KRW | 233.55% |
| 2018 Q3 | 69.00 KRW | 221.14% |
| 2018 Q1 | -39.86 KRW | 56.82% |
| 2017 FY | - KRW | -275.95% |
| 2017 Q3 | -95.00 KRW | 42.33% |
| 2017 Q2 | -164.73 KRW | -1375.99% |
| 2017 Q4 | -92.31 KRW | 2.83% |
| 2017 Q1 | 12.91 KRW | 116.09% |
| 2016 Q2 | -13.00 KRW | -226.46% |
| 2016 Q3 | -19.43 KRW | -49.46% |
| 2016 Q4 | -80.26 KRW | -313.07% |
| 2016 FY | - KRW | 57.83% |
| 2016 Q1 | 10.28 KRW | 102.7% |
| 2015 Q1 | 21.46 KRW | 0.0% |
| 2015 Q4 | -380.69 KRW | -945.98% |
| 2015 FY | - KRW | 0.0% |
| 2015 Q3 | 45.00 KRW | 478.41% |
| 2015 Q2 | 7.78 KRW | -63.75% |
| 2014 Q1 | 5.84 KRW | 103.54% |
| 2014 Q2 | 37.80 KRW | 547.26% |
| 2014 Q3 | 28.25 KRW | -25.26% |
| 2013 Q4 | -165.15 KRW | -4028.75% |
| 2013 Q1 | -33.56 KRW | 87.04% |
| 2013 Q3 | -4.00 KRW | -107.05% |
| 2013 Q2 | 56.74 KRW | 269.07% |
| 2013 FY | - KRW | 50.86% |
| 2012 Q3 | -72.00 KRW | 0.0% |
| 2012 Q4 | -258.99 KRW | -259.71% |
| 2012 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 109.684% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | 151.707% |
| Bioneer Corporation | -410.19 KRW | 136.822% |
| Anterogen.Co.,Ltd. | -291.93 KRW | 151.738% |
| MEDIPOST Co., Ltd. | 287.00 KRW | 47.373% |
| CrystalGenomics, Inc. | -661.00 KRW | 122.85% |
| Helixmith Co., Ltd | -1543.76 KRW | 109.784% |
| Chabiotech Co.,Ltd. | -149.80 KRW | 200.828% |
| Medy-Tox Inc. | 1456.65 KRW | 89.631% |
| Peptron, Inc. | -773.61 KRW | 119.524% |
| Amicogen, Inc. | -583.58 KRW | 125.882% |
| Genexine, Inc. | -1652.14 KRW | 109.142% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | 570.237% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 105.82% |
| ALTEOGEN Inc. | -65.27 KRW | 331.408% |
| PharmaResearch Co., Ltd. | 7502.00 KRW | 97.987% |
| SillaJen, Inc. | -179.98 KRW | 183.92% |
| JETEMA, Co., Ltd. | 783.21 KRW | 80.715% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | 111.409% |
| Genomictree Inc. | -391.00 KRW | 138.629% |
| MedPacto, Inc. | -1664.87 KRW | 109.072% |
| D&D Pharmatech | 409.19 KRW | 63.088% |
| EASY BIO,Inc. | 455.00 KRW | 66.804% |
| GI Innovation, Inc. | -1285.69 KRW | 111.748% |